These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23259514)

  • 1. Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study.
    Sarris J; Laporte E; Scholey A; King R; Pipingas A; Schweitzer I; Stough C
    Traffic Inj Prev; 2013; 14(1):13-7. PubMed ID: 23259514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study.
    Sarris J; Scholey A; Schweitzer I; Bousman C; Laporte E; Ng C; Murray G; Stough C
    Hum Psychopharmacol; 2012 May; 27(3):262-9. PubMed ID: 22311378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
    J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is driving under the influence of kava associated with motor vehicle crashes? A systematic review of the epidemiological literature.
    Wainiqolo I; Kool B; Nosa V; Ameratunga S
    Aust N Z J Public Health; 2015 Oct; 39(5):495-9. PubMed ID: 26337520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Kava-Special Extract WS 1490 combined with ethyl alcohol on safety-relevant performance parameters].
    Herberg KW
    Blutalkohol; 1993 Mar; 30(2):96-105. PubMed ID: 8481222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacopsychological effects of oxazepam and kava-extract in a visual search paradigm assessed with event-related potentials.
    Heinze HJ; Münthe TF; Steitz J; Matzke M
    Pharmacopsychiatry; 1994 Nov; 27(6):224-30. PubMed ID: 7870743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
    Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
    Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
    Ramaekers JG
    J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of on-the-road experimental studies of hypnotics: effects of time after intake, dose, and half-life.
    Roth T; Eklov SD; Drake CL; Verster JC
    Traffic Inj Prev; 2014; 15(5):439-45. PubMed ID: 24678565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute effects of 3,4-methylenedioxymethamphetamine and methamphetamine on driving: a simulator study.
    Stough C; Downey LA; King R; Papafotiou K; Swann P; Ogden E
    Accid Anal Prev; 2012 Mar; 45():493-7. PubMed ID: 22269534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies.
    Leufkens TR; Vermeeren A
    Clin Ther; 2014 Jan; 36(1):141-50. PubMed ID: 24360801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo.
    Leufkens TR; Vermeeren A
    J Clin Psychopharmacol; 2009 Oct; 29(5):432-8. PubMed ID: 19745642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
    Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG
    Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
    Sarris J; Kavanagh DJ; Deed G; Bone KM
    Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.
    Sarris J; Byrne GJ; Bousman CA; Cribb L; Savage KM; Holmes O; Murphy J; Macdonald P; Short A; Nazareth S; Jennings E; Thomas SR; Ogden E; Chamoli S; Scholey A; Stough C
    Aust N Z J Psychiatry; 2020 Mar; 54(3):288-297. PubMed ID: 31813230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.
    Jongen S; Vuurman EFPM; Ramaekers JG; Vermeeren A
    Psychopharmacology (Berl); 2018 Apr; 235(4):1283-1294. PubMed ID: 29500585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
    Gastpar M; Klimm HD
    Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of single-dose Ginkgo biloba and Panax ginseng on driving performance.
    LaSala GS; McKeever RG; Patel U; Okaneku J; Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2015 Feb; 53(2):108-12. PubMed ID: 25597699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
    Farber RH; Burke PJ
    Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.